{"id":"W2141100300","doi":"10.3816/ccc.2010.n.043","title":"Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer","year":2010,"lang":"en","type":"article","venue":"Clinical Colorectal Cancer","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Bevacizumab; Erlotinib; Oxaliplatin; Internal medicine; Colorectal cancer; FOLFOX; Rash; Mucositis; Gastroenterology; Neutropenia; Fluorouracil; Oncology; Chemotherapy; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002072466,0.001859887,0.003019089,0.0005390851,0.000568237,0.001481421,0.001309435,0.001866747,0.005177769],"category_scores_gemma":[0.001519839,0.0009583918,0.001854205,0.0005356431,0.001495927,0.001444373,0.0004532829,0.00496863,0.001177102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002040789,"about_ca_system_score_gemma":0.002194722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003239872,"about_ca_topic_score_gemma":0.008046133,"domain_scores_codex":[0.9994331,0.0002577275,0.00002505015,0.0001044239,0.00003586451,0.0001438779],"domain_scores_gemma":[0.9986732,0.0002530958,0.0002156938,0.00009230139,0.0000589239,0.0007067237],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9358416,0.02204349,0.001056096,0.000386964,0.001068947,0.00008184981,0.0001265861,0.001367285,0.00573394,0.0002705972,0.002635594,0.02938705],"study_design_scores_gemma":[0.8501914,0.1438141,0.002611926,0.00002215372,0.0003742017,0.00008811097,0.0000445894,0.0007725036,0.0008157875,0.0001754316,0.001069716,0.00002012395],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889415,0.002934124,0.0005273974,0.001159115,0.0003914328,0.001809044,0.001148857,0.000125826,0.002962716],"genre_scores_gemma":[0.9856243,0.002178711,0.001673175,0.00117899,0.0002804808,0.001906808,0.002577561,0.00004263272,0.004537325],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005177769,"threshold_uncertainty_score":0.01732135,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04145720672408924,"score_gpt":0.4011696703099102,"score_spread":0.3597124635858209,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}